Federal Food, Drug, and Cosmetic Act, 21 U.S.C
Why GLP-1s are Biologically Plausible for Alzheimers Beyond lowering glucose and weight, GLP-1 signaling appears to: Improve insulin signaling in the brain Dampen neuroinflammation (microglial activation) Reduce oxidative stress Interact with amyloid- and tau pathways in preclinical models Recent peer-reviewed reviews synthesize these mechanisms and frame GLP-1s as potential multi-target neuroprotective agents rather than single-pathway drugs
By combining advanced medications with a modern, telehealth-first approach, we help you focus on your health without the stress of waiting rooms or hidden fees
A spokeswoman for Novo Nordisk, the Danish company that makes Ozempic and Wegovy, says the company does not promote, suggest, or encourage off-label use of our medicines. We trust that healthcare providers are evaluating a patients individual needs and determining which medicine is right for that particular patient, Allison Schneider wrote in a statement